MEA Traceability

Azerbaijan has emerged as a regional leader in pharmaceutical security through the implementation of its mandatory medicine tracking and tracing system. Under the oversight of the Ministry of Health's Analytical Expertise Center, the country has established a robust regulatory framework designed to ensure complete transparency and accountability throughout the pharmaceutical supply chain. This comprehensive system represents Azerbaijan's commitment to protecting public health by preventing counterfeit medicines and maintaining the highest standards of pharmaceutical integrity.

In Bahrain, the National Health Regulatory Authority (NHRA) establishes comprehensive regulations to safeguard pharmaceutical integrity throughout the supply chain. The NHRA's stringent regulatory framework represents Bahrain's dedication to ensuring medication authenticity, patient safety, and supply chain transparency through advanced traceability and verification systems.

Egypt has established a comprehensive regulatory framework for pharmaceuticals through the Egyptian Pharmaceutical Track & Trace System (EPTTS), overseen by the Ministry of Health and Population. This pioneering initiative represents Egypt's commitment to safeguarding public health by ensuring the authenticity, safety, and traceability of medicinal products throughout the entire pharmaceutical supply chain.

In Ethiopia, the Ethiopian Food and Drug Authority (EFDA) plays a pivotal role in ensuring the safety, efficacy, and quality of pharmaceuticals. Central to its regulatory framework is the EFDA Traceability Directive, a comprehensive set of requirements designed to bolster the traceability of medicinal products within the pharmaceutical supply chain.

Iran has established a sophisticated pharmaceutical regulatory system designed to ensure the safety, efficacy, and quality of medicinal products throughout the country. The Iranian Food and Drug Administration (IFDA), operating under the Ministry of Health and Medical Education, serves as the primary regulatory authority overseeing all aspects of pharmaceutical oversight. This comprehensive framework reflects Iran's commitment to maintaining stringent standards that protect public health while facilitating access to essential medicines.

Iraq has established a comprehensive pharmaceutical regulatory framework through its National Drug System (المنظومة الوطنية للدواء), administered via the Gudea portal. This pioneering digital platform represents Iraq's commitment to enhancing drug safety, combating counterfeit medications, and ensuring complete transparency throughout the pharmaceutical supply chain. The system mandates rigorous tracking and tracing protocols for all pharmaceutical products, whether domestically manufactured or imported, creating an integrated ecosystem that protects patients while supporting regulatory oversight.